Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Methodologies for the isolation of alternative binders with improved clinical potentiality over conventional antibodies.

de Marco A.

Crit Rev Biotechnol. 2013 Mar;33(1):40-8. doi: 10.3109/07388551.2012.665353. Epub 2012 Apr 4. Review.

PMID:
22475460
2.

Semiautomated panning of naive camelidae libraries and selection of single-domain antibodies against peptide antigens.

Kumaran J, Mackenzie CR, Arbabi-Ghahroudi M.

Methods Mol Biol. 2012;911:105-24. doi: 10.1007/978-1-61779-968-6_7.

PMID:
22886248
3.

Selection of recombinant antibodies from antibody gene libraries.

Hust M, Frenzel A, Schirrmann T, Dübel S.

Methods Mol Biol. 2014;1101:305-20. doi: 10.1007/978-1-62703-721-1_14.

PMID:
24233787
4.

Phage display technology: clinical applications and recent innovations.

Azzazy HM, Highsmith WE Jr.

Clin Biochem. 2002 Sep;35(6):425-45. Review.

PMID:
12413604
5.

Platelet integrin alpha2 I-domain specific antibodies produced via domain specific DNA vaccination combined with variable gene phage display.

Hughes DL, Stafford P, Hamaia SW, Harmer lJ, Schoolmeester A, Deckmyn H, Farndale RW, Ouwehand WH, Watkins NA.

Thromb Haemost. 2005 Dec;94(6):1318-26.

PMID:
16411412
6.

Isolation of Camelid Single-Domain Antibodies Against Native Proteins Using Recombinant Multivalent Peptide Ligands.

Alturki NA, Henry KA, MacKenzie CR, Arbabi-Ghahroudi M.

Methods Mol Biol. 2015;1348:167-89. doi: 10.1007/978-1-4939-2999-3_16.

PMID:
26424272
7.

Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.

Dincq S, Bosman F, Buyse MA, Degrieck R, Celis L, de Boer M, Van Doorsselaere V, Sablon E.

Protein Expr Purif. 2001 Jun;22(1):11-24.

PMID:
11388794
8.

Selection by phage display of single domain antibodies specific to antigens in their native conformation.

Verheesen P, Laeremans T.

Methods Mol Biol. 2012;911:81-104. doi: 10.1007/978-1-61779-968-6_6.

PMID:
22886247
9.

Isolation of monoclonal antibody fragments from phage display libraries.

Arbabi-Ghahroudi M, Tanha J, MacKenzie R.

Methods Mol Biol. 2009;502:341-64. doi: 10.1007/978-1-60327-565-1_20.

PMID:
19082566
10.

Surface display of a single-domain antibody library on Gram-positive bacteria.

Fleetwood F, Devoogdt N, Pellis M, Wernery U, Muyldermans S, Ståhl S, Löfblom J.

Cell Mol Life Sci. 2013 Mar;70(6):1081-93. doi: 10.1007/s00018-012-1179-y. Epub 2012 Oct 13.

PMID:
23064703
11.

Phage ESCape: an emulsion-based approach for the selection of recombinant phage display antibodies.

Kiss MM, Babineau EG, Bonatsakis M, Buhr DL, Maksymiuk GM, Wang D, Alderman D, Gelperin DM, Weiner MP.

J Immunol Methods. 2011 Mar 31;367(1-2):17-26. doi: 10.1016/j.jim.2010.09.034. Epub 2010 Oct 7.

PMID:
20932970
12.

Isolation of anti-mesothelin antibodies from a phage display library.

Chowdhury PS, Chang K, Pastan I.

Mol Immunol. 1997 Jan;34(1):9-20.

PMID:
9182872
13.

Generation and isolation of target-specific single-domain antibodies from shark immune repertoires.

Müller MR, O'Dwyer R, Kovaleva M, Rudkin F, Dooley H, Barelle CJ.

Methods Mol Biol. 2012;907:177-94. doi: 10.1007/978-1-61779-974-7_9.

PMID:
22907351
14.

Phage diabody repertoires for selection of large numbers of bispecific antibody fragments.

McGuinness BT, Walter G, FitzGerald K, Schuler P, Mahoney W, Duncan AR, Hoogenboom HR.

Nat Biotechnol. 1996 Sep;14(9):1149-54.

PMID:
9631069
15.

Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches.

Even-Desrumeaux K, Fourquet P, Secq V, Baty D, Chames P.

Mol Biosyst. 2012 Sep;8(9):2385-94. Epub 2012 Jul 6.

PMID:
22772166
16.

Selecting and purifying autonomous human variable heavy (VH) domains.

Tonikian R, Sidhu SS.

Methods Mol Biol. 2012;911:327-53. doi: 10.1007/978-1-61779-968-6_20.

PMID:
22886261
17.

Multivalent display of single-domain antibodies.

Zhang J, Mackenzie CR.

Methods Mol Biol. 2012;911:445-56. doi: 10.1007/978-1-61779-968-6_27.

PMID:
22886268
18.

Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.

McCall AM, Adams GP, Amoroso AR, Nielsen UB, Zhang L, Horak E, Simmons H, Schier R, Marks JD, Weiner LM.

Mol Immunol. 1999 May;36(7):433-45.

PMID:
10449096
19.
20.

Engineering of stable bispecific antibodies targeting IL-17A and IL-23.

Mabry R, Lewis KE, Moore M, McKernan PA, Bukowski TR, Bontadelli K, Brender T, Okada S, Lum K, West J, Kuijper JL, Ardourel D, Franke S, Lockwood L, Vu T, Frank A, Appleby MW, Wolf A, Reardon B, Hamacher NB, Stevens B, Lewis P, Lewis KB, Gilbertson DG, Lantry M, Julien SH, Ostrander C, Chan C, Byrnes-Blake K, Brody J, Presnell S, Meengs B, Levin SD, Snavely M.

Protein Eng Des Sel. 2010 Mar;23(3):115-27. doi: 10.1093/protein/gzp073. Epub 2009 Dec 18.

PMID:
20022918

Supplemental Content

Support Center